Altogether, our data indicate that EpCAM CAR-T cells exhibit antitumor functions against pancreatic cancer PDOs, and further exploring the clinical benefits would be valuable to the pancreatic cancer therapy. This evidence concerns the gene EPCAM and familial pancreatic carcinoma.